New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bionano Genomics, Inc.
BNGO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

25M

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

25M

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

0.30USD
Shape0.00 ( 0.27%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

39%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

87%

Quote Panel

Shape
Updated October 25, 2024
1W -7.77 % 1M -33.03 % 3M -52.85 % 1Y -77.61 %

Key Metrics

Shape
  • Market Cap

    25.42M


  • Shares Outstanding

    86.00M


  • Share in Float

    85.45M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    0.2956


  • Average Volume

    1.81M


  • Beta

    2.325


  • Range

    0.28-2.27


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.bionanogenomics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.69x

P/S Ratio

0.25x

P/B Ratio

0.3

Debt/Equity

-558.0%

Net Margin

$9.9

EPS

How BNGO compares to sector?

P/E Ratio

Relative Strength

Shape

BNGO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$43M

Shape452%

2025-Revenue

$0.48

Shape-101%

2025-EPS

$43M

Shape-149%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

BTIG

downgrade

Previous: Buy

2024-09-10

Now: Neutral

Scotiabank

downgrade

Previous: Sector Outperform

2024-08-28

Now: Sector Perform

EF Hutton

initialise

Previous: Not converted

2023-05-25

Now: Buy

Scotiabank

initialise

Previous: Not converted

2023-01-05

Now: Sector Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.10
vs -0.70

Q4.22

arrow
arrow

N/A

-1.30
vs -0.80

Q1.23

arrow
arrow

N/A

-1.20
vs -1.10

Q2.23

arrow
arrow

N/A

-1.24
vs -1.10

Q3.23

arrow
arrow

N/A

-1.48
vs -1.10

Q4.23

arrow
arrow

N/A

-0.96
vs -1.30

Q1.24

arrow
arrow

N/A

-0.60
vs -1.20

Q2.24

arrow
arrow

N/A

-0.24
vs -1.24

Q3.24

arrow
arrow

N/A

-0.20
vs -1.48

Q4.24

arrow
arrow

N/A

-0.18
vs -0.96

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+55%

7.2M  vs 4.7M

Q4.22

arrow
arrow

+30%

8.2M  vs 6.3M

Q1.23

arrow
arrow

+30%

7.4M  vs 5.7M

Q2.23

arrow
arrow

+30%

8.7M  vs 6.7M

Q3.23

arrow
arrow

+29%

9.3M  vs 7.2M

Q4.23

arrow
arrow

+31%

10.7M  vs 8.2M

Q1.24

arrow
arrow

+18%

8.8M  vs 7.4M

Q2.24

arrow
arrow

-10%

7.8M  vs 8.7M

Q3.24

arrow
arrow

-12%

8.2M  vs 9.3M

Q4.24

arrow
arrow

+10%

11.8M  vs 10.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-11%

-0.11
vs -0.11

Q4.22

arrow
arrow

-16%

-0.16
vs -0.11

Q1.23

arrow
arrow

-16%

-0.16
vs -0.16

Q2.23

arrow
arrow

-18%

-0.18
vs -0.16

Q3.23

arrow
arrow

-95%

-0.95
vs -0.18

Q4.23

arrow
arrow

-46%

-0.46
vs -0.95

Q1.24

arrow
arrow

-38%

-0.38
vs -0.46

Q2.24

arrow
arrow

-20%

-0.20
vs -0.38

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

169

169
vs 175

-3%

Q4.21

arrow
arrow

171

171
vs 169

1%

Q1.22

arrow
arrow

163

163
vs 171

-5%

Q2.22

arrow
arrow

152

152
vs 163

-7%

Q3.22

arrow
arrow

151

151
vs 152

-1%

Q4.22

arrow
arrow

160

160
vs 151

6%

Q1.23

arrow
arrow

136

136
vs 160

-15%

Q2.23

arrow
arrow

124

124
vs 136

-9%

Earnings Growth

Latest News